• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Methodology of hemodynamic study of a vasodilator drug (author's transl)].

作者信息

Morgant C, Merillon J P, Motte G, Guiomard A, Gourgon R

出版信息

Anesth Analg (Paris). 1980;37(9-10):561-6.

PMID:7469072
Abstract

The mechanism of action of a vasodilator drug is complex and depends on its predominant site of action: arterial or venous system. it leads to a) complex alteration of ventricular load that changes cardiac output, b) alteration of myocardial energetic metabolism. To classify a vasodilator drug, it is useful to study: a) its mechanism of action on the peripheral vascular system, b) the left ventricular function, and c) the coronary blood flow and the myocardial metabolism. The peripheral action of the drug is assessed by simultaneous measurement of peripheral blood flow, arterial pressure and venous pressure. From these data, arterial resistance (AR) and venous tone (VT) are calculated. A change of AR and for VT permits to classify a vasodilator drug as arterial, venous or both arterial and venous. Changes of factors of ventricular load are appreciated by measurement of aortic pressure, left ventricular pressure and ventricular volumes. If no change of heart rate occures, modification of stroke volume and cardiac output is due to a reduction of end diastolic volume (venous vasodilator drug) or of end systolic volume (arterial vasodilator drug).

摘要

相似文献

1
[Methodology of hemodynamic study of a vasodilator drug (author's transl)].
Anesth Analg (Paris). 1980;37(9-10):561-6.
2
[Methods for evaluating vasodilator agents in cardiac failure].[评估心力衰竭中血管扩张剂的方法]
Arch Mal Coeur Vaiss. 1990 Mar;83 Spec No 2:63-7.
3
[Effect of high dosages of morphine and meperidine on haemodynamics, coronary blood flow and myocardial oxygen consumption in comparison to fentanyl and piritramide (author's transl)].[与芬太尼和匹利卡明相比,高剂量吗啡和哌替啶对血流动力学、冠状动脉血流量及心肌耗氧量的影响(作者译)]
Anaesthesist. 1977 May;26(5):239-48.
4
Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs.左西孟旦对开胸猪右心室功能及心室血管耦联的影响。
Crit Care Med. 2003 Sep;31(9):2339-43. doi: 10.1097/01.CCM.0000084844.95073.C0.
5
Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.吸入一氧化氮:对机械诱导肺动脉高压犬的血流动力学、心肌收缩力及局部血流的影响
J Heart Lung Transplant. 1996 Jul;15(7):700-8.
6
Effects of nifedipine on total cardiac output distribution in conscious rat.
J Pharmacol Exp Ther. 1984 Mar;228(3):711-8.
7
The effects of acetylstrophanthidin and glucocorticoids on canine left ventricular performance and coronary hemodynamics.
Circ Shock. 1980;7(3):265-76.
8
Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.AR-L 115 BS对心肌耗氧量、心脏功能以及血管阻力和容量的作用。
Arzneimittelforschung. 1981;31(1a):151-4.
9
[Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].经冠状动脉内注射双嘧达莫在经皮腔内冠状动脉成形术(PTCA)期间的药理心肌保护作用:血流动力学、收缩功能及心室动态变化
Z Kardiol. 1995 Nov;84(11):898-910.
10
Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.硝普钠在慢性缺血性心脏病中的临床应用。对周围血管阻力、静脉张力以及心室容积、泵功能和机械性能的影响。
Circulation. 1975 Feb;51(2):328-36. doi: 10.1161/01.cir.51.2.328.